Ischemic nephropathy: clinical characteristics and treatment

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Geriatrics

Background:

• Ischemic nephropathy is an increasingly recognized cause of chronic hypertension and end-stage renal disease.
• Rising incidence is linked to an aging population and higher prevalence of hypertension and diabetes.
• Atherosclerosis is a common comorbidity affecting multiple vascular beds.

Purpose of the Study:

• To review the clinical presentation and management of patients with ischemic nephropathy.
• To discuss therapeutic options including surgical revascularization and endovascular interventions.
• To highlight the progressive nature and multifactorial aspects of this condition.

Main Methods:

• This is a review article synthesizing current knowledge on ischemic nephropathy.
• Clinical profiles, diagnostic considerations, and treatment outcomes are discussed.
• Evidence from surgical and interventional procedures is evaluated.

Main Results:

• Ischemic nephropathy often presents progressively but can manifest as acute renal failure.
• Revascularizing surgery demonstrates potential to stabilize or improve renal function, even in severely compromised kidneys.
• Intraluminal angioplasty shows poorer outcomes with high restenosis rates; endoprothesis placement is advised for specific arterial locations.

Conclusions:

• Ischemic nephropathy is a complex, progressive disease requiring individualized patient assessment.
• Surgical revascularization offers a viable treatment option for renal function improvement.
• Endovascular techniques, particularly stenting, are indicated for specific lesion types to manage renal artery stenosis.